↑Pitts, Ferris N; Allen, Robert E; Aniline, Orm; Burgoyne, Rodney W (August 1982). "The Dilemma of the Toxic Psychosis: Differential Diagnosis and the PCP Psychosis". Psychiatric Annals. 12 (8): 762–8. doi:10.3928/0048-5713-19820801-07. OCLC5584879101.
↑
Tien, AY; Anthony, JC (August 1990). "Epidemiological analysis of alcohol and drug use as risk factors for psychotic experiences". J. Nerv. Ment. Dis. 178 (8): 473–80. doi:10.1097/00005053-199017880-00001. PMID2380692.
↑
Cargiulo, T (March 2007). "Understanding the health impact of alcohol dependence". Am J Health Syst Pharm. 64 (5 Suppl 3): S5-11. doi:10.2146/ajhp060647. PMID17322182.
↑Schuckit, MA (November 1983). "Alcoholism and other psychiatric disorders". Hosp Community Psychiatry. 34 (11): 1022–7. doi:10.1176/ps.34.11.1022. PMID6642446.
↑Degenhardt, L (January 2003). "The link between cannabis use and psychosis: furthering the debate". Psychological Medicine. 33 (1): 3–6. doi:10.1017/S0033291702007080. PMID12537030.
↑
de Paola, L; Mäder, MJ; Germiniani, FM; และคณะ (June 2004). "Bizarre behavior during intracarotid sodium amytal testing (Wada test): are they predictable?". Arquivos de Neuro-Psiquiatria. 62 (2B): 444–8. doi:10.1590/S0004-282X2004000300012. PMID15273841.
↑
Sarrecchia, C; Sordillo, P; Conte, G; Rocchi, G (1998). "[Barbiturate withdrawal syndrome: a case associated with the abuse of a headache medication]". Annali Italiani di Medicina Interna (ภาษาอิตาลี). 13 (4): 237–9. PMID10349206.
↑
White, MC; Silverman, JJ; Harbison, JW (February 1982). "Psychosis associated with clonazepam therapy for blepharospasm". The Journal of Nervous and Mental Disease. 170 (2): 117–9. doi:10.1097/00005053-198202000-00010. PMID7057171.
↑
Cerimele, JM; Stern, AP; Jutras-Aswad, D (March 2010). "Psychosis following excessive ingestion of energy drinks in a patient with schizophrenia". The American Journal of Psychiatry. 167 (3): 353. doi:10.1176/appi.ajp.2009.09101456. PMID20194494.
↑Wada, K; Nakayama, K; Koishikawa, H; Katayama, M; Hirai, S; Yabana, T; และคณะ (2005). "Symptomatological structure of volatile solvent-induced psychosis: is "solvent psychosis" a discernible syndrome?". 日本アルコール・薬物医学会雑誌 = [Japanese Journal of Alcohol Studies & Drug Dependence]. 40 (5): 471–484. PMID16316074.
↑Jung, IK; Lee, HJ; Cho, BH (December 2004). "Persistent psychotic disorder in an adolescent with a past history of butane gas dependence". European Psychiatry. 19 (8): 519–20. doi:10.1016/j.eurpsy.2004.09.010. PMID15589716.
↑Hernandez-Avila, Carlos A; Ortega-Soto, Hector A; Jasso, Antonio; Hasfura-Buenaga, Cecilia A; Kranzler, Henry R (1998). "Treatment of Inhalant-Induced Psychotic Disorder With Carbamazepine Versus Haloperidol". Psychiatric Services. 49 (6): 812–815. doi:10.1176/ps.49.6.812. PMID9634163.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
↑
Sexton, J. D.; Pronchik, D. J. (1997). "Diphenhydramine-induced psychosis with therapeutic doses". The American Journal of Emergency Medicine. 15 (5): 548–549. doi:10.1016/S0735-6757(97)90212-6. PMID9270406.
↑
Lang, K.; Sigusch, H.; Müller, S. (1995). "Anticholinergisches Syndrom mit halluzinatorischer Psychose nach Diphenhydramin-Intoxikation" [An anticholinergic syndrome with hallucinatory psychosis after diphenhydramine poisoning]. Deutsche Medizinische Wochenschrift (ภาษาเยอรมัน). 120 (49): 1695–1698. doi:10.1055/s-2008-1055530. PMID7497894.
↑
Schreiber, W.; Pauls, A. M.; Krieg, J. C. (1988). "Toxische Psychose als Akutmanifestation der Diphenhydraminvergiftung" [Toxic psychosis as an acute manifestation of diphenhydramine poisoning]. Deutsche Medizinische Wochenschrift (ภาษาเยอรมัน). 113 (5): 180–183. doi:10.1055/s-2008-1067616. PMID3338401.
↑
Timnak, C.; Gleason, O. (2004). "Promethazine-Induced Psychosis in a 16-Year-Old Girl". Psychosomatics. 45 (1): 89–90. doi:10.1176/appi.psy.45.1.89. PMID14709767.
↑Hall, R. C.; Popkin, M. K.; Stickney, S. K.; Gardner, E. R. (1979). "Presentation of the steroid psychoses". The Journal of Nervous and Mental Disease. 167 (4): 229–236. doi:10.1097/00005053-197904000-00006. PMID438794.
↑Hull, PR; D'Arcy, C (2003). "Isotretinoin Use and Subsequent Depression and Suicide: Presenting the Evidence". American Journal of Clinical Dermatology. 4 (7): 493–505. doi:10.2165/00128071-200304070-00005. PMID12814338.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
↑
Bergman, K. R.; Pearson, C.; Waltz, G. W.; Evans R. III (1980). "Atropine-induced psychosis. An unusual complication of therapy with inhaled atropine sulfate". Chest. 78 (6): 891–893. doi:10.1378/chest.78.6.891. PMID7449475.
↑
Varghese, S.; Vettath, N.; Iyer, K.; Puliyel, J. M.; Puliyel, M. M. (1990). "Ocular atropine induced psychosis--is there a direct access route to the brain?". Journal of the Association of Physicians of India. 38 (6): 444–445. PMID2384469.
↑Barak, Segev; Weiner, I. (2006). "Scopolamine Induces Disruption of Latent Inhibition Which is Prevented by Antipsychotic Drugs and an Acetylcholinesterase Inhibitor". Neuropsychopharmacology. 32 (5): 989–999. doi:10.1038/sj.npp.1301208. PMID16971898.
↑Gaylord, Ellison (1995). "The N-methyl-d-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementias". Brain Research Reviews. 20 (2): 250–267. doi:10.1016/0165-0173(94)00014-G. PMID7795658.
↑Carey, R. J.; Pinheiro-Carrera, M.; Dai, H.; Tomaz, C.; Huston, J. P. (1995). "l-DOPA and psychosis: Evidence for l-DOPA-induced increases in prefrontal cortex dopamine and in serum corticosterone". Biological Psychiatry. 38 (10): 669–676. doi:10.1016/0006-3223(94)00378-5. PMID8555378.
↑
Every-Palmer, S (2010). "Warning: legal synthetic cannabinoid-receptor agonists such as JWH-018 may precipitate psychosis in vulnerable individuals". Addiction. 105 (10): 1859–60. doi:10.1111/j.1360-0443.2010.03119.x. PMID20840203.
↑
Müller, H; และคณะ (2010). "The synthetic cannabinoid Spice as a trigger for an acute exacerbation of cannabis induced recurrent psychotic episodes". Schizophr. Res. 118 (1–3): 309–10. doi:10.1016/j.schres.2009.12.001. PMID20056392.